To illustrate the role of APP, PSEN1, and PSEN2 in AD endophenotypes, we conducted AAO, MMSE, MoCA, CDR, and cerebrospinal fluid (CSF) biomarkers association studies in AD patients. This evidence concerns the gene PSEN1 and Alzheimer disease.